Hudson Bay Capital Management LP Myriad Genetics Inc Transaction History

Hudson Bay Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $163,730 - $236,851	11,284 New	11,284 $163,000
Q4 2019 Feb 12, 2020	SELL	$20.93 - $35.1 $732,550 - $1.23 Million	-35,000 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $331,200 - $706,200	-15,000 Reduced 30.0%	35,000 $1 Million
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $1.13 Million - $1.75 Million	50,000 New	50,000 $1.39 Million
Q2 2018 Aug 13, 2018	SELL	$27.75 - $40.17 $1.39 Million - $2.01 Million	-50,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $1.44 Million - $2.05 Million	50,000 New	50,000 $1.48 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.